Patent details

Basic Information

Publication number:

EP1789433

PCT Application Number:

PCT/US/2004/023649

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP047789417

PCT Publication Number:

WO/2005/010025

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHODS OF TREATING CUTANEOUS FLUSHING USING SELECTIVE ALPHA-2-ADRENERGIC RECEPTOR AGONISTS

French Title of Invention:

METHODES DE TRAITEMENT DE BOUFFEES VASOMOTRICES AVEC MANIFESTATION CUTANEE AU MOYEN D'AGONISTES SELECTIFS DES RECEPTEURS ALPHA-2-ADRENERGIQUES

German Title of Invention:

VERFAHREN ZUR BEHANDLUNG VON ERRÖTEN DER HAUT UNTER VERWENDUNG VON SELEKTIVEN AGONISTEN DES ALPHA-2-ADRENERGEN REZEPTORS

SPC Number:

Dates

Filing date:

21/07/2004

Grant date:

06/06/2012

EP Publication Date:

06/06/2012

PCT Publication Date:

03/02/2005

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/05/2007

EP B1 Publication Date:

06/06/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/07/2015

Expiration date:

21/07/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/07/2004

 

 

Name:

Galderma Pharma S.A.

Address:

World Trade Center Avenue Gratta-Paille 1, 1000 Lausanne 30 Grey, Switzerland (CH)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

13/06/2012

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

Name:

SCHERER Warren J.

Address:

United States (US)

Priority

Priority Number:

626037

Priority Date:

23/07/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

C07K 1/00;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages